|
|
Zyvox - Newsfeeds
-
-
... of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment. The ...
-
-
... milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment. The enrollment of ...
-
-
was warned by the Food and Drug Administration that its ‘misleading promotion’ of linezolid (Zyvox) as a treatment for a wide range of methicillin-resistant Staphylococcus aureus (MRSA) infections ‘poses ...
-
-
Oral and IV formulations of PTK 0796 were compared to Zyvox ® in a Phase 2 clinical study in complicated skin and skin structure infections (cSSSI). In addition to PTK 0796, Paratek is also developing other ...
-
-
... once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox) for 10 ...
-
-
The study reports on 12 critically ill patients who were found to be infected with the first reported cases of linezolid-resistant Staphylococcus aureus . Linezolid is an antibiotic and one of the few options left to ...
-
-
An outbreak of infection due to linezolid and methicillin-resistant StaphylococcuS aureus (LRSA) in 12 intensive care unit patients in Spain was associated with transmission within the hospital and extensive usage of the ...
-
-
Illinois health officials yesterday said they had confirmed 12 more cases of Salmonella serotype Hvittingfoss in people who ate at Subway restaurants, raising the total so far to 60. They also said Subway restaurants in ...
-
-
June 8, 2010 -- First there were methicillin-resistant Staphylococcus aureus ( MRSA ) infections. Now there is linezolid -resistant Staphylococcus aureus (LRSA), according to new research in the June 9 issue of the ...
-
-
... oral administration of 200 milligrams of torezolid phosphate over six days of treatment to twice-daily oral administration of 600 milligrams of linezolid (Zyvox) for 10 days of treatment. The primary efficacy ...
-
-
Department of Justice to pay $2.3 billion to settle claims arising from the illegal marketing of some drugs, including the painkiller Bextra; Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug. Among the charges ...
-
-
furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine), phenothiazines (e.g., chlorpromazine), thyroid hormones (e.g., levothyroxine), tricyclic antidepressants (e.g., amitriptyline ...
-
-
furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine), other pain medications, tricyclic antidepressants (e.g., doxepin). Tell your doctor or pharmacist if you also take drugs that ...
-
-
The trial is designed to assess the safety and efficacy of NXL103 in comparison to oral linezolid (Zyvox, Pfizer NYSE:PFE). Travelport Advocates for Better Worldwide Crisis Coordination at the Transatlantic Business Dialogue Executive Board Meeting ...
-
-
... Pharmacia & Upjohn agree to pay $2.3 billion to settle charges that they illegally promoted numerous drugs, including the painkiller Bextra, anti-psychotic drug Geodon, antibiotic Zyvox and anti-epilepsy drug Lyrica. Oct. 29: AstraZeneca ...
-
-
The trial is designed to assess the safety and efficacy of NXL103 in comparison to oral linezolid (Zyvox, Pfizer NYSE:PFE). The comparative Phase II trial with NXL103 is a prospective, multicenter, investigator-blinded, two-arm, parallel group study ...
-
-
... looking to proceed to Phase 3 clinical trials of its antibiotic, torezolid, which Trius describes as a second-generation successor to linezolid, the Pfizer antibiotic known as Zyvox. Even when I sat down with Trius CEO Jeff Stein seven months ...
-
-
The biotech is poised for Phase III trials with an antibiotic intended to improve on Pfizer ’s Zyvox (linezolid) and has filed to raise $86 million. Investors may be willing to fork it over, too, considering that Trius’s drug has sparked lots of ...
-
-
These patients often have little recourse, and their physicians turn as a last resort to agents such as linezolid that have considerable adverse events after prolonged administration. TMC207 appears not to be associated with serious adverse events, at ...
-
-
-- 4-8 fold greater potency than linezolid in vitro and in vivo-- In vivo bactericidal activity-- Activity against all clinically important, gram-positive, drug-resistant strains including those resistant to linezolid-- Activity against clinically ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
1
2
Next
|
|
